NewDays

新日子

, a Seattle startup using a generative AI therapy to treat people with mild dementia, has raised additional funding and closed its seed round with $16 million. The funding was led by Madrona and General Catalyst.

一家位于西雅图的初创公司，利用生成式人工智能疗法治疗轻度痴呆症患者，已筹集额外资金，并以1600万美元完成种子轮融资。本轮融资由Madrona和General Catalyst领投。

The company also announced on Wednesday that it has expanded its services to Nevada, joining Washington, California, Florida, Texas, and New York. NewDays offers telehealth visits with human clinicians once or twice a month alongside unlimited conversations with an AI companion named Sunny.

该公司还在周三宣布，已将服务扩展至内华达州，与华盛顿州、加利福尼亚州、佛罗里达州、得克萨斯州和纽约州并列。NewDays 提供每月一至两次的人类临床医生远程医疗问诊，以及不限次数地与名为 Sunny 的 AI 伴侣进行对话。

“Our goal isn’t to add years — it’s to add quality to the years people have,” said CEO and Co-Founder

“我们的目标不是增加寿命，而是提升人们已有岁月的生活质量，”首席执行官兼联合创始人表示

Babak Parviz

巴巴克·帕尔维兹

.

。

The startup is addressing a widespread issue: one in three Americans over 65 experiences cognitive decline, with 11% living with dementia and another 22% with mild cognitive impairment. Patients use Sunny to engage in conversational topics, memory exercises, and language or reasoning games designed to strengthen cognitive function..

这家初创公司正致力于解决一个普遍存在的问题：在美国，65岁以上的人群中，每三人就有一人经历认知衰退，其中11%患有痴呆症，另有22%患有轻度认知障碍。患者使用Sunny参与对话话题、记忆练习以及旨在增强认知功能的语言或推理游戏。

“While these cognitive strategies are clinically proven, they have historically lacked broad accessibility,” Parviz said. “NewDays aims to make treatment scalable using AI and demonstrate measurable improvement.”

“尽管这些认知策略在临床上已被证实有效，但它们在历史上一直缺乏广泛的普及性，”帕尔维兹表示。“NewDays 旨在利用人工智能实现治疗的可扩展性，并展示出可衡量的改善效果。”

This past July at the annual Alzheimer’s Association International Conference, the company

在今年七月举行的阿尔茨海默病协会国际会议上，该公司

presented research

展示的研究

showing that NewDays patients with dementia performed better on cognitive tests than expected historical decline curves — translating to roughly 18 months of preserved cognitive function. The study was limited to 24 patients, half of whom have dementia and the other half experiencing other cognitive impairment..

结果显示，患有痴呆症的 NewDays 患者在认知测试中的表现优于预期的历史衰退曲线，相当于保留了约 18 个月的认知功能。该研究仅纳入 24 名患者，其中一半患有痴呆症，另一半则存在其他类型的认知障碍。

“Generative AI under the guidance of an expert human clinician is what finally lets us deliver a medically proven intervention at that scale. That’s the whole thesis of the company,” Parviz said via email.

“在人类临床专家的指导下，生成式人工智能最终使我们能够大规模提供经医学验证的干预措施。这正是该公司的核心理念。”帕尔维兹通过电子邮件表示。

To further validate its platform, NewDays is currently running a randomized controlled trial with Kaiser Permanente in California.

为进一步验证其平台，NewDays 目前正在加利福尼亚州与凯撒医疗集团开展一项随机对照试验。

Users can try Sunny for free. If they’re interested in the full program, there is a free 20-minute assessment to evaluate suitability. NewDays is covered by traditional Medicare and is working to secure in-network status with private insurers and Medicare Advantage plans. Participants in the program also have the option of paying $150 out-of-pocket for each clinical session..

用户可以免费试用 Sunny。如果他们对完整计划感兴趣，可以进行一次免费的20分钟评估，以判断是否适合。NewDays 已被传统医疗保险（Medicare）覆盖，并正在努力与私人保险公司及 Medicare Advantage 计划达成网络内合作。该计划的参与者也可以选择为每次临床疗程自费支付150美元。

Originally announced September 2nd, 2026

最初于2026年9月2日宣布

Get Fresh Healthcare & IT Stories Delivered Daily

每日获取最新的医疗与IT资讯

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万的医疗保健与健康IT同行，订阅我们的每日通讯。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不会出售或泄露您的联系方式。